Other
Rehabilitation
0
Pipeline Programs↗
16
Active Trials↗
3
Companies Involved↗
Rehabilitation is an early-stage landscape with 0 programs across 3 companies. The most active players are Boehringer Ingelheim, Bayer, Ipsen.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
51
clinical trials
Completed20 · 39%
Unknown status8 · 16%
Recruiting7 · 14%
Active, not recruiting5 · 10%
Terminated5 · 10%
Not yet recruiting4 · 8%
Other2 · 4%
Clinical Trials
Trial Activity
51 trials
Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy
Recruiting·—·N/A·NCT04985695·110 enrolled
Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients
Recruiting·—·N/A·NCT07167368·60 enrolled
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
Active, not recruiting·TTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan·N/A·NCT04702542·320 enrolled
The Heart Health After Cardiac Treatment Study
Active, not recruiting·UUniversity of California, San Francisco·Preclinical·NCT07158515·100 enrolled
Intra-articular Injection Versus Normal Rehabilitation Therapy on Temporomandibular Joint Dysfunction
Not yet recruiting·—·N/A·NCT06328998·80 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)